Pilot Programme Study Results underpinning NHS Implementation Guide for CYP2C19 Genotype Testing Presented at the UK Stroke Forum genedrive plc (AIM: GDR), the point of care pharmacogenetic testing ...
Consent is an important consideration if introducing testing. A patient expert highlighted that people who have had a stroke often have severe cognitive impairment, may have difficulty with their ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback